CANCER Limitations of therapies exposed

被引：31
作者：
Casanovas, Oriol [1 ]
机构：
[1] Bellvitge Inst Biomed Res, Catalan Inst Oncol, Translat Res Lab, E-08907 Lhospitalet De Llobregat, Spain
来源：
NATURE | 2012年 / 484卷 / 7392期
关键词：
ANTI-ANGIOGENIC THERAPY; ANTIANGIOGENIC THERAPY; TUMOR VASCULATURE; BREAST-CANCER; STEM-CELLS; METASTASIS; RESISTANCE; BEVACIZUMAB; COMBINATION; INHIBITOR;
D O I：
10.1038/484044a
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
[No abstract available]
引用
收藏
页码：44 / 46
页数：3
相关论文
共 18 条
  • [1] AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients
    Batchelor, Tracy T.
    Sorensen, A. Gregory
    di Tomaso, Emmanuelle
    Zhang, Wei-Ting
    Duda, Dan G.
    Cohen, Kenneth S.
    Kozak, Kevin R.
    Cahill, Daniel P.
    Chen, Poe-Jou
    Zhu, Mingwang
    Ancukiewicz, Marek
    Mrugala, Maciej M.
    Plotkin, Scott
    Drappatz, Jan
    Louis, David N.
    Ivy, Percy
    Scadden, David T.
    Benner, Thomas
    Loeffler, Jay S.
    Wen, Patrick Y.
    Jain, Rakesh K.
    [J]. CANCER CELL, 2007, 11 (01) : 83 - 95
  • [2] Modes of resistance to anti-angiogenic therapy
    Bergers, Gabriele
    Hanahan, Douglas
    [J]. NATURE REVIEWS CANCER, 2008, 8 (08) : 592 - 603
  • [3] Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
    Boehm, T
    Folkman, J
    Browder, T
    OReilly, MS
    [J]. NATURE, 1997, 390 (6658) : 404 - 407
  • [4] Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform
    Casazza, Andrea
    Kigel, Boaz
    Maione, Federica
    Capparuccia, Lorena
    Kessler, Ofra
    Giraudo, Enrico
    Mazzone, Massimiliano
    Neufeld, Gera
    Tamagnone, Luca
    [J]. EMBO MOLECULAR MEDICINE, 2012, 4 (03) : 234 - 250
  • [5] Aldehyde Dehydrogenase 1-Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer
    Charafe-Jauffret, Emmanuelle
    Ginestier, Christophe
    Iovino, Flora
    Tarpin, Carole
    Diebel, Mark
    Esterni, Benjamin
    Houvenaeghel, Gilles
    Extra, Jean-Marc
    Bertucci, Francois
    Jacquemier, Jocelyne
    Xerri, Luc
    Dontu, Gabriela
    Stassi, Giorgio
    Xiao, Yi
    Barsky, Sanford H.
    Birnbaum, Daniel
    Viens, Patrice
    Wicha, Max S.
    [J]. CLINICAL CANCER RESEARCH, 2010, 16 (01) : 45 - 55
  • [6] Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia
    Conley, Sarah J.
    Gheordunescu, Elizabeth
    Kakarala, Pramod
    Newman, Bryan
    Korkaya, Hasan
    Heath, Amber N.
    Clouthier, Shawn G.
    Wicha, Max S.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (08) : 2784 - 2789
  • [7] Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
    Ebos, John M. L.
    Lee, Christina R.
    Cruz-Munoz, William
    Bjarnason, Georg A.
    Christensen, James G.
    Kerbel, Robert S.
    [J]. CANCER CELL, 2009, 15 (03) : 232 - 239
  • [8] Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors
    Folkins, Chris
    Man, Shan
    Xu, Ping
    Shaked, Yuval
    Hicklin, Daniel J.
    Kerbel, Robert S.
    [J]. CANCER RESEARCH, 2007, 67 (08) : 3560 - 3564
  • [9] Bevacizurnab in combination with fluorouracil and leucovorin: An active regimen for first-line metastatic colorectal cancer
    Hurwitz, HI
    Fehrenbacher, L
    Hainsworth, JD
    Heim, W
    Berlin, J
    Holmgren, E
    Hambleton, J
    Novotny, WF
    Kabbinavar, F
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) : 3502 - 3508
  • [10] Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy
    Jain, RK
    [J]. NATURE MEDICINE, 2001, 7 (09) : 987 - 989
12